Skip to content

Delivering Successful Companion Diagnostics Programs: A Large Global Central Laboratory’s Experience

Time: 12:00 pm
day: Day One


  • Describing some of the trends in the data to support companion diagnostic submissions and approval, seen by a Central Laboratory, that
    is supporting over 100 CDx clinical trials
  • Other approaches required to maximize the potential of predictive biomarker assays, given the small number of CDx approvals since the first 20 years ago
  • Trends and best practice will be described on how CDx assays are supporting clinical development in China